Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters

Database
Language
Affiliation country
Publication year range
1.
Mitochondrial DNA B Resour ; 5(3): 2201-2202, 2020.
Article in English | MEDLINE | ID: mdl-33366971

ABSTRACT

Lycium chinense is an important edible and medicinal plant. Now, the complete chloroplast (cp) genome of L. chinense was assembled based on the Illumina sequencing reads. The cp genome of L. chinense was 155,736 bp long and contained two short inverted repeat regions (25,469 bp), which were separated by a small single-copy region (18,206 bp) and a large single-copy region (86,592 bp). The cp genome encodes 113 unique genes, including 79 protein-coding genes, 30 transfer RNA genes, and 4 ribosomal RNA genes. The topology of the phylogenetic tree showed that L. chinense is closely clustered with species Lycium ruthenicum and Lycium barbarum.

2.
Mitochondrial DNA B Resour ; 5(3): 2203-2204, 2020.
Article in English | MEDLINE | ID: mdl-33366972

ABSTRACT

Morus alba is an important medicinal plant that is used to treat human diseases. The complete chloroplast (cp) genome of M. alba was assembled based on the Illumina sequencing reads. The cp genome of M. alba was 159,290 bp and contained two short inverted repeat regions (25,690 bp) which were separated by a small single copy region (19,845 bp) and a large single copy region (88,065 bp). The cp genome encodes 111 unique genes, including 77 protein-coding genes, 30 transfer RNA genes and four ribosomal RNA genes. The topology of the phylogenetic tree showed that M. alba is closely clustered with species M. cathayana and M. mongolica.

3.
Mitochondrial DNA B Resour ; 5(3): 2205-2206, 2020.
Article in English | MEDLINE | ID: mdl-33366973

ABSTRACT

Poncirus trifoliata is an important medicinal plant that is used to treat human diseases. In this study, the complete chloroplast (cp) genome of P. trifoliata was assembled based on the Illumina sequencing reads. The cp genome of P. trifoliata was 160,260 bp and contained two short inverted repeat regions (27,029 bp) which were separated by a small single copy region (18,760 bp) and a large single copy region (87,442 bp). The cp genome encodes 113 unique genes, including 79 protein-coding genes, 30 transfer RNA genes and 4 ribosomal RNA genes. The topology of the phylogenetic tree showed that P. trifoliata is closely clustered with genus Citrus.

4.
Molecules ; 25(1)2020 Jan 02.
Article in English | MEDLINE | ID: mdl-31906524

ABSTRACT

Moringa oleifera Lam. (MO) is called the "Miracle Tree" because of its extensive pharmacological activity. In addition to being an important food, it has also been used for a long time in traditional medicine in Asia for the treatment of chronic diseases such as diabetes and obesity. In this study, by constructing a library of MO phytochemical structures and using Discovery Studio software, compounds were subjected to virtual screening and molecular docking experiments related to their inhibition of dipeptidyl peptidase (DPP-IV), an important target for the treatment of type 2 diabetes. After the four-step screening process, involving screening for drug-like compounds, predicting the absorption, distribution, metabolism, excretion, and toxicity (ADME/T) of pharmacokinetic properties, LibDock heatmap matching analysis, and CDOCKER molecular docking analysis, three MO components that were candidate DPP-IV inhibitors were identified and their docking modes were analyzed. In vitro activity verification showed that all three MO components had certain DPP-IV inhibitory activities, of which O-Ethyl-4-[(α-l-rhamnosyloxy)-benzyl] carbamate (compound 1) had the highest activity (half-maximal inhibitory concentration [IC50] = 798 nM). This study provides a reference for exploring the molecular mechanisms underlying the anti-diabetic activity of MO. The obtained DPP-IV inhibitors could be used for structural optimization and in-depth in vivo evaluation.


Subject(s)
Dipeptidyl-Peptidase IV Inhibitors/chemistry , Moringa oleifera/chemistry , Binding Sites , Diabetes Mellitus, Type 2/drug therapy , Dipeptidyl Peptidase 4/metabolism , Dipeptidyl-Peptidase IV Inhibitors/therapeutic use , Humans , Hypoglycemic Agents/therapeutic use , Molecular Docking Simulation , Protein Binding , Structure-Activity Relationship
SELECTION OF CITATIONS
SEARCH DETAIL